"Hyperglycemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high BLOOD GLUCOSE level.
Descriptor ID |
D006943
|
MeSH Number(s) |
C18.452.394.952
|
Concept/Terms |
Hyperglycemia, Postprandial- Hyperglycemia, Postprandial
- Hyperglycemias, Postprandial
- Postprandial Hyperglycemias
- Postprandial Hyperglycemia
|
Below are MeSH descriptors whose meaning is more general than "Hyperglycemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperglycemia".
This graph shows the total number of publications written about "Hyperglycemia" by people in this website by year, and whether "Hyperglycemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 2 | 1 | 3 |
2015 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperglycemia" by people in Profiles.
-
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment. Diabetologia. 2022 Nov; 65(11):1770-1781.
-
Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes. Diabetes Obes Metab. 2017 06; 19(6):866-873.
-
Aldehyde dehydrogenase activity is necessary for beta cell development and functionality in mice. Diabetologia. 2016 Jan; 59(1):139-150.
-
Regulation of liver metabolism by the endosomal GTPase Rab5. Cell Rep. 2015 May 12; 11(6):884-892.
-
Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care. 2012 Sep; 35(9):1891-3.
-
Prediabetes: a high-risk state for diabetes development. Lancet. 2012 Jun 16; 379(9833):2279-90.
-
Hexosamine pathway activation and O-linked-N-acetylglucosamine: novel mediators of endothelial dysfunction in hyperglycemia and diabetes. Vascul Pharmacol. 2012 Mar-Apr; 56(3-4):113-4.